Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study-Reference-Cited by-同舟云学术

Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study

Published:2022-01 Issue:1 Volume:28 Page:50.e1-50.e8
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Carreira Abel Santos^ORCID,Salas Maria Queralt,Remberger Mats^ORCID,Basso Igor Novitzky,Law Arjun Datt,Lam Wilson,Pasic Ivan,Kim Dennis,Michelis Fotios V.,Viswabandya Auro,Gerbitz Armin,Lipton Jeffrey Howard,Husain Shahid,Kumar Rajat,Mattsson Jonas

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference36 articles.

1. Hematopoietic stem-cell transplantation;Copelan;N Engl J Med,2006

2. Current use and trends in hematopoietic cell transplantation in the United States;D'Souza;Biol Blood Marrow Transplant,2017

3. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia;Maertens;J Antimicrob Chemother,2018

4. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016;Ullmann;Ann Hematol,2016

5. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations;Blennow;Transpl Infect Dis,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventional antibiotic treatment replacing antibiotic prophylaxis during allogeneic hematopoietic stem cell transplantation is safe and leads to a reduction of antibiotic administration;Annals of Hematology;2024-09-06

2. Safety and efficacy of G-CSF after allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide: clinical and in vitro examination of endothelial activation;Bone Marrow Transplantation;2024-08-08

3. The utility of temporal trends of blood biomarkers as predictors for bloodstream infections in left ventricular assist device recipients;Artificial Organs;2024-08-06

4. Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study;Cancers;2024-07-17

5. Effectiveness of Pre-Transplant Screening for High-Priority Multidrug-Resistant Pathogens on Pre-Engraftment Infections After Hematopoietic Stem Cell Transplantation;Infection and Drug Resistance;2024-06